login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
TRAVERE THERAPEUTICS INC (TVTX) Stock News
NASDAQ:TVTX -
US89422G1076
-
Common Stock
19.61
USD
+1.46 (+8.04%)
Last: 9/3/2025, 8:00:01 PM
19.61
USD
0 (0%)
After Hours:
9/3/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TVTX Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism
7 days ago - By: Benzinga
- Mentions:
NVS
VOR
FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari
7 days ago - By: Investor's Business Daily
Travere Flirts With A Breakout As FDA Decision Bolsters Filspari's Launch
7 days ago - By: Benzinga
- Mentions:
NVDA
WYNN
COO
PVH
...
Nvidia To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
8 days ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Announces U.S. FDA Approves REMS Modification for FILSPARI® (sparsentan) in IgA Nephropathy
24 days ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About Travere (TVTX) Q2 Earnings
a month ago - By: Zacks Investment Research
- Mentions:
ALVO
Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates
a month ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Reports Second Quarter 2025 Financial Results
a month ago - By: Travere Therapeutics, Inc.
Travere Therapeutics to Participate at Upcoming Investor Conferences
a month ago - By: Travere Therapeutics, Inc.
Travere Therapeutics to Report Second Quarter 2025 Financial Results
2 months ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: Yahoo Finance
Leerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
3 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX
3 months ago - By: Yahoo Finance
- Mentions:
VZ
TELO
REGN
Guide to refinancing an FHA loan to a conventional loan
3 months ago - By: Yahoo Finance
- Mentions:
SGHC
BLK
SCHW
LPLA
...
BTIG Stays Bullish on Super Group (SGHC) Limited (SGHC) Amid Sportsbook Optimism
3 months ago - By: Yahoo Finance
- Mentions:
AZN
CHWY
SCHW
LPLA
...
Spectris rejects second KKR proposal in favour of Advent's $5 billion bid
3 months ago - By: Yahoo Finance
- Mentions:
TELO
Middle East conflict threatens to exacerbate inflationary pressure on some things
3 months ago - By: Yahoo Finance
- Mentions:
KOD
APLS
TELO
SCHW
...
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
3 months ago - By: Yahoo Finance
- Mentions:
TELO
HWKN
DKNG
FLUT
TELO Rises on Promising Telomir-1 Preclinical Results
3 months ago - By: Travere Therapeutics, Inc.
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.